SCHEMBL334755

SCHEMBL334755

Ic1cnccc1-c1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 10/20 0.56
CYP3A4 P08684 5/20 0.56
CYP1A2 P05177 4/20 0.56
ALDH1A1 P00352 2/20 0.56
GSK3B P49841 1/20 0.51
DYRK1A Q13627 1/20 0.51
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP2E1 P05181 4/20 0.46
CYP2D6 P10635 4/20 0.46
CYP2C9 P11712 4/20 0.46
CYP2C19 P33261 4/20 0.46
TDO2 P48775 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5700526 0.85 TNF (0.48) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B
SCHEMBL19961427 0.83 CYP2A6 (0.56) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B
SCHEMBL23889758 0.77 CYP2A6 (0.49) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B
SCHEMBL14883110 0.77 CYP2A6 (0.48) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B
SCHEMBL30732664 0.77 CYP2A6 (0.58) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B
SCHEMBL18373406 0.76 CYP2A6 (0.51) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL1491549 0.76 CYP2A6 (0.64) CYP2A6CYP3A4CYP1A2ALDH1A1KDM4E
SCHEMBL10205403 0.75 CYP19A1 (0.61) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B
SCHEMBL28114956 0.75 RPS6KA3 (0.62) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B
SCHEMBL15783990 0.75 CYP2A6 (0.56) CYP2A6CYP3A4CYP1A2ALDH1A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097594-B2 Macrolides and ketolides having antimicrobial activity WOCKHARDT LTD. (IN) 2012-01-17 US disclosed
US-20090247478-A1 Novel macrolides and ketolides having antimicrobial activity SINDKHEDKAR MILIND DATTATRAYA 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247478-A1 Novel macrolides and ketolides having antimicrobial activity CYP51A1, CASP12, LSS CYP2A6 814/4885CYP3A4 422/4885CYP1A2 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.